WHO HAS TO UNDERGO CANCER GENETIC TESTING? A PERSPECTIVE.
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Authors
Genctic testing is a medical tool employed to screen changes in genes linked to cancer and other genetic discases. Genetic tests are available for breast, ovarian, colon, thyroid, and some other cancers and they represent the main tool for early identification of the "risk" subjects.
The choice to undergo genctic testing by a healthy or affected cancer patient with family history of the cancer has to be the fruit of a careful and prudent assessment of the advantages and disad vantage: discussed during oncogenctic counselling. The latter, in tum, in the case of patient's positive and informed choice, must constantly affiliate the genetic testing, in order 10 preserve the prediction and information role of the test as much as possible.
Downloads
Citations
How to Cite
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.